‘We overdrove our headlights’: After his biotech startup fails, a CEO reflects on what went wrong

The South San Francisco biotech company was founded in 2014 to focus on discovering drugs to treat rare diseases. It won backing from the startup accelerator Y Combinator, a handful of seed-stage investors, and the venture capital firm of Mark Cuban, the billionaire of Shark Tank fame.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!